CCM
MRK icon

Cribstone Capital Management’s Merck MRK Stock Holding History

Cribstone Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.49M Sell
13,427
-1,443
-10% -$147K 0.87% 32
2022
Q3 		$1.28M Sell
14,870
-787
-5% -$70.3K 0.79% 38
2022
Q2 		$1.43M Sell
15,657
-2,535
-14% -$225K 0.88% 31
2022
Q1 		$1.49M Buy
18,192
+889
+5% +$70.1K 0.82% 33
2021
Q4 		$1.33M Buy
17,303
+848
+5% +$67.5K 0.74% 34
2021
Q3 		$1.24M Buy
16,455
+3,207
+24% +$244K 0.74% 37
2021
Q2 		$1.03M Sell
13,248
-181
-1% -$13.5K 0.62% 42
2021
Q1 		$988K Buy
13,429
+2,583
+24% +$191K 0.65% 42
2020
Q4 		$847K Buy
10,846
+218
+2% +$16.7K 0.58% 47
2020
Q3 		$841K Sell
10,628
-1,251
-11% -$98K 0.69% 41
2020
Q2 		$877K Buy
11,879
+486
+4% +$36.6K 0.73% 43
2020
Q1 		$836K Sell
11,393
-194
-2% -$15.2K 0.88% 31
2019
Q4 		$1.01M Sell
11,587
-6,580
-36% -$540K 0.9% 37
2019
Q3 		$1.46M Sell
18,167
-2,980
-14% -$239K 0.88% 37
2019
Q2 		$1.69M Sell
21,147
-445
-2% -$34.1K 0.92% 34
2019
Q1 		$1.71M Sell
21,592
-7,091
-25% -$530K 0.9% 34
2018
Q4 		$2.09M Sell
28,683
-176
-0.6% -$12.4K 1.07% 29
2018
Q3 		$1.95M Buy
28,859
+1,506
+6% +$95.9K 0.9% 34
2018
Q2 		$1.58M Buy
27,353
+1,509
+6% +$85.1K 0.78% 35
2018
Q1 		$1.34M Buy
25,844
+2,426
+10% +$131K 0.66% 43
2017
Q4 		$1.27M Buy
23,418
+2,777
+13% +$154K 0.6% 44
2017
Q3 		$1.27M Sell
20,641
-1,986
-9% -$120K 0.66% 44
2017
Q2 		$1.39M Sell
22,627
-1,028
-4% -$62.6K 0.76% 45
2017
Q1 		$1.43M Buy
23,655
+10,638
+82% +$645K 0.78% 44
2016
Q4 		$777K Sell
13,017
-107
-0.8% -$6.26K 0.48% 62
2016
Q3 		$782K Sell
13,124
-565
-4% -$33K 0.48% 61
2016
Q2 		$753K Buy
13,689
+408
+3% +$21.7K 0.47% 56
2016
Q1 		$671K Buy
13,281
+1,191
+10% +$58.3K 0.54% 57
2015
Q4 		$608K Buy
+12,090
New +$610K 0.5% 59

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cribstone Capital Management's MRK Position: Q4 2022 in Review

Cribstone Capital Management reduced its Merck (MRK) stake by 9.7% in Q4 2022, selling an estimated $147K and leaving 13,427 shares worth $1.49M. The position accounts for 0.87% of the portfolio, ranked #32.

Cribstone Capital Management first reported a position in MRK in Q4 2015 and has held it in 29 quarters since. The position peaked at $2.09M in Q4 2018. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Cribstone Capital Management held 13,427 shares of Merck worth $1.49M as of Q4 2022.
  • Cribstone Capital Management sold 1,443 Merck shares in Q4 2022, an estimated $147K.
  • Merck made up 0.87% of Cribstone Capital Management's portfolio in Q4 2022, its #32 holding.
  • Cribstone Capital Management first reported a position in Merck in Q4 2015 and has held it in 29 quarters since.
  • Cribstone Capital Management's Merck position peaked at $2.09M in Q4 2018.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.